Redhill Biopharma
RDHL
$0.43
Share price
2.22%
Change (1 day)
-81.23%
Change (1 year)
Categories
Redhill Biopharma (RDHL) - Total debt
Total debt on the balance sheet as of June 2023 : $2.28 M
According to Redhill Biopharma's latest financial reports the company's total debt is $2.28 M. A company’s total debt is the sum of all current and non-current debts.
Redhill Biopharma - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | 39.72% |
| 2021-12-31 | $87.81 M | 1.05% |
| 2020-12-31 | $86.9 M | 2177.93% |
| 2019-12-31 | $3.81 M | |
| 2018-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $20.36 B | 891,629.42% | 🇫🇷 France |
 Merck MRK | $35.05 B | 1,534,707.36% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $22.93 B | 1,004,142.56% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $20.15 B | 882,255.52% | 🇮🇱 Israel |
 Taro Pharmaceutical TARO | $1.95 M | -14.62% | 🇮🇱 Israel |